期刊文献+

血清超敏C反应蛋白检测在糖尿病大血管病变中的意义

Clinical significance of detection of serum high-sensitivity C-reactive protein in diabetic macroangiopathy
下载PDF
导出
摘要 目的探讨超敏C反应蛋白(hs-CRP)与2型糖尿病并发大血管病变的相关性。方法采用散射比浊法测定50例2型糖尿病患者(其中并发大血管病变者20例)和30例健康对照者血清hs-CRP的水平,并进行分析。结果2型糖尿病组hs-CRP水平与健康对照组比较明显升高,差异具有统计学意义(P<0.05);并发大血管病变患者hs-CRP明显高于非大血管病变者,差异具有统计学意义(P<0.05)。结论hs-CRP在2型糖尿病并发大血管病变患者中显著升高,可能是2型糖尿病大血管病变的一个重要的独立危险因素。 Objective To investigate the correlation of high-sensitivity C reactive protein(hs-CRP) and mac roangiopathy complicated by type 2 diabetes mellitus. Methods The serum level of hs-CRP was determined with scattered turbidimetric method in 50 patients with type 2 diabetes mellitus(DM group,in which 20 cases were complicated with diabetic macroangiopathy) and 30 healthy controls(healthy control group). Results Serum hs-CRP level were significantly elevated in DM group as compared with that of healthy control group(P〈0.05). There was asta tistical difference of hs CRP level between type 2 diabetes mellitus patients with and without macroangiopathy(P〈 0.05). Conclusion Serum hs-CRP level is markedly increased in patients with type 2 diabetes mellitus,which may be an important and independent risk factor for macroangiopathy complicated by type 2 diabetes mellitus.
出处 《检验医学与临床》 CAS 2008年第21期1285-1286,共2页 Laboratory Medicine and Clinic
关键词 C反应蛋白质 糖尿病 2型 糖尿病血管病变 C-reactive protein diabetes mellitus,type 2 diabetic agiopathies
  • 相关文献

参考文献5

二级参考文献33

  • 1[1]Ross R.Atherosclerosis:an inflammatory disease[J].N Engl J Med,1999,340:115-126.
  • 2[3]Folsom AR,Aleksic N,Catellier D,et al.C-reactive protein and incident coronary heart disease in the atherosclerosis risk in communities (ARIC) study[J].Am Heart J,2002,144(2):233.
  • 3[4]Ridker PM,Cushman M,Stampfer MJ,et al.Plasma concentration of C-reactive proteinan drisk of developing peripheralvascular disease[J].Circulation,1998,97:425-428.
  • 4[5]Luiji M,Biasucci H,Liuzzo G,et al.Elevated levels of C-reactive protein at discharge inpatients with unstable an ginapredictre currentinstability[J].Circulation,1999,99:855-992.
  • 5Yudkin JS , Stehouwer CD , Emeis JJ , et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfuction: a potential role for cytokines originating from adipose tissue. Arerioscler Thromb Vase Biol ,
  • 6Marz W, Wieland H. HMG-CoA reductase inhibition: anti inflammatory effects beyond lipid lowering. Herz , 2000 , 25 : 117-125.
  • 7Hojo Y , Ikeda U, Katsuki T , et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart, 2000,84: 83 -87.
  • 8Davies MJ. The pathophysiology of acute coronary syndromes.Heart , 2000 , 83 : 361-366.
  • 9Anderson JL , Caripuist JF , Muhlestein JB , et al. Evalution of Creactive protein. an inflammatory marker and infection serology as risk factor for coronary artery disease and myocardial infarction. J Am Coil Caridol , 1998 , 32: 35-38.
  • 10叶任高.内科学第5版[M].北京:人民卫生出版社,2002.471—479.

共引文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部